Búsqueda | Biblioteca Virtual en Salud

1.

Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism.

Colvin, Gerald A; Berz, David; Ramanathan, Muthalagu; Winer, Eric S; Fast, Loren; Elfenbein, Gerald J; Quesenberry, Peter J.

Biol Blood Marrow Transplant ; 15(4): 421-31, 2009 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-19285629

2.

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.

Kumar, Shaji; Pérez, Waleska S; Zhang, Mei-Jie; Ballen, Karen; Bashey, Asad; To, L Bik; Bredeson, Christopher N; Cairo, Mitchell S; Elfenbein, Gerald J; Freytes, César O; Gale, Robert Peter; Gibson, John; Kyle, Robert A; Lacy, Martha Q; Lazarus, Hillard M; McCarthy, Philip L; Milone, Gustavo A; Moreb, Jan S; Pavlovsky, Santiago; Reece, Donna E; Vesole, David H; Wiernik, Peter H; Hari, Parameswaran.

Biol Blood Marrow Transplant ; 14(10): 1134-1140, 2008 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-18804043

3.

Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer.

Davol, Pamela A; Bagdasaryan, Robert; Elfenbein, Gerald J; Maizel, Abby L; Frackelton, A Raymond.

Cancer Res ; 63(20): 6772-83, 2003 Oct 15.

Artículo en Inglés | MEDLINE | ID: mdl-14583473

4.

A decline in breast-cancer incidence.

Elfenbein, Gerald J.

N Engl J Med ; 357(5): 509; author reply 513, 2007 Aug 02.

Artículo en Inglés | MEDLINE | ID: mdl-17674463

5.

Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.

Elfenbein, Gerald J; Sackstein, Robert.

Exp Hematol ; 32(4): 327-39, 2004 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-15050742

6.

Anti-CD3 x anti-HER2 bispecific antibody effectively redirects armed T cells to inhibit tumor development and growth in hormone-refractory prostate cancer-bearing severe combined immunodeficient beige mice.

Davol, Pamela A; Smith, Janelle A; Kouttab, Nicola; Elfenbein, Gerald J; Lum, Lawrence G.

Clin Prostate Cancer ; 3(2): 112-21, 2004 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-15479495

7.

Novel approaches in the treatment of multiple myeloma.

Abedi, Mehrdad; Elfenbein, Gerald J.

Med Health R I ; 86(8): 231-5, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14582216

8.

The chronic leukemias: current and novel therapeutic approaches.

Rathore, Ritesh; Elfenbein, Gerald J.

Med Health R I ; 86(8): 240-2, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14582218

9.

The latest treatment advances for acute myelogenous leukemia.

Colvin, Gerald A; Elfenbein, Gerald J.

Med Health R I ; 86(8): 243-6, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14582219

10.

Stem-cell transplantation for high-risk breast cancer.

Elfenbein, Gerald J.

N Engl J Med ; 349(1): 80-2, 2003 Jul 03.

Artículo en Inglés | MEDLINE | ID: mdl-12840096

11.

Phase I/II study of treatment of stage IV breast cancer with OKT3 x trastuzumab-armed activated T cells.

Lum, Lawrence G; Rathore, Ritesh; Cummings, Frank; Colvin, Gerald A; Radie-Keane, Kathy; Maizel, Abby; Quesenberry, Peter J; Elfenbein, Gerald J.

Clin Breast Cancer ; 4(3): 212-7, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14499016

12.

Blood and marrow stem cell transplantation at the Roger Williams Medical Center, 1999-2001.

Elfenbein, Gerald J.

Med Health R I ; 85(4): 118-24, 2002 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-11989398

13.

Implications of lack of concordance among oncologists for evidence-based medicine derived clinical guidelines.

Elfenbein, Gerald J.

Med Health R I ; 86(8): 228-30, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14582215

14.

New therapeutic approaches to non-Hodgkin's lymphomas.

Lambert, Jean-François F; Elfenbein, Gerald J.

Med Health R I ; 86(8): 236-9, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14582217

15.

Persistent candidemia in a leukemic after allogeneic transplantation.

Khorsand, Jila; Falvey, Mary T; Elfenbein, Gerald J.

Med Health R I ; 86(8): 251, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14582222

16.

Future prospects for patient care utilizing autologous lymphoid and hematopoietic stem cells.

Lum, Lawrence G; Rathore, Ritesh; Quesenberry, Peter J; Elfenbein, Gerald J.

Med Health R I ; 86(8): 247-8, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14582220

17.

Neoadjuvant therapy with high dose chemotherapy via isolated pelvic intra-abdominal perfusion with bone marrow stem cell support for advanced endometrial cancer.

Delaney, Meghan; Stancu, Mirela; Begossi, Giovanni; Elfenbein, Gerald J; Wanebo, Harold J.

Med Health R I ; 86(8): 252-5, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14582223

18.

Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?

Elfenbein, Gerald J.

Pediatr Transplant ; 9 Suppl 7: 37-47, 2005 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-16305616

19.

ABO blood group barrier in allogeneic bone marrow transplantation revisited.

Seebach, Jörg D; Stussi, Georg; Passweg, Jakob R; Loberiza, Fausto R; Gajewski, James L; Keating, Armand; Goerner, Martin; Rowlings, Philip A; Tiberghien, Pierre; Elfenbein, Gerald J; Gale, Robert Peter; van Rood, Jon J; Reddy, Vijay; Gluckman, Eliane; Bolwell, Brian J; Klumpp, Thomas R; Horowitz, Mary M; Ringdén, Olle; Barrett, A John.

Biol Blood Marrow Transplant ; 11(12): 1006-13, 2005 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-16338623

20.

Do G-CSF mobilized, peripheral blood-derived stem cells from healthy, HLA-identical donors really engraft more rapidly than do G-CSF primed, bone marrow-derived stem cells? No!

Elfenbein, Gerald J; Sackstein, Robert; Oblon, David J.

Blood Cells Mol Dis ; 32(1): 106-11, 2004.

Artículo en Inglés | MEDLINE | ID: mdl-14757423

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism.

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.

Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer.

A decline in breast-cancer incidence.

Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.

Anti-CD3 x anti-HER2 bispecific antibody effectively redirects armed T cells to inhibit tumor development and growth in hormone-refractory prostate cancer-bearing severe combined immunodeficient beige mice.

Novel approaches in the treatment of multiple myeloma.

The chronic leukemias: current and novel therapeutic approaches.

The latest treatment advances for acute myelogenous leukemia.

Stem-cell transplantation for high-risk breast cancer.

Phase I/II study of treatment of stage IV breast cancer with OKT3 x trastuzumab-armed activated T cells.

Blood and marrow stem cell transplantation at the Roger Williams Medical Center, 1999-2001.

Implications of lack of concordance among oncologists for evidence-based medicine derived clinical guidelines.

New therapeutic approaches to non-Hodgkin's lymphomas.

Persistent candidemia in a leukemic after allogeneic transplantation.

Future prospects for patient care utilizing autologous lymphoid and hematopoietic stem cells.

Neoadjuvant therapy with high dose chemotherapy via isolated pelvic intra-abdominal perfusion with bone marrow stem cell support for advanced endometrial cancer.

Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?

ABO blood group barrier in allogeneic bone marrow transplantation revisited.

Do G-CSF mobilized, peripheral blood-derived stem cells from healthy, HLA-identical donors really engraft more rapidly than do G-CSF primed, bone marrow-derived stem cells? No!